上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002252 上海莱士

已收盘 12-12 15:00:00

{"stockData":{"symbol":"002252","market":"SZ","secType":"STK","nameCN":"上海莱士","latestPrice":6.44,"timestamp":1765523004000,"preClose":6.43,"halted":0,"volume":34442535,"delay":0,"changeRate":0.0016,"floatShares":6634000000,"shares":6638000000,"eps":0.2752,"marketStatus":"已收盘","change":0.01,"latestTime":"12-12 15:00:00","open":6.43,"high":6.44,"low":6.4,"amount":221000000,"amplitude":0.0062,"askPrice":6.44,"askSize":8637,"bidPrice":6.43,"bidSize":2234,"shortable":0,"etf":0,"ttmEps":0.2752,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.43,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":7.07,"lowLimit":5.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637984837,"isCdr":false,"pbRate":1.31,"roa":"--","peRate":23.401163,"roe":"4.55%","epsLYR":0.33,"committee":0.097569,"marketValue":42749000000,"turnoverRate":0.0052,"status":0,"floatMarketCap":42726000000},"requestUrl":"/m/hq/s/002252","defaultTab":"news","newsList":[{"id":"2589867133","title":"上海莱士：截至2025年10月31日股东总户数为111,626户","url":"https://stock-news.laohu8.com/highlight/detail?id=2589867133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589867133?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:27","pubTimestamp":1764923242,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月31日，公司总的股东户数是多少？谢谢。上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年10月31日，公司股东总户数为111,626户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500022004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0239","002252","BK0028","BK0188"],"gpt_icon":0},{"id":"2588033948","title":"上海莱士：截至2025年11月28日股东户数为110,144户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033948","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033948?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:27","pubTimestamp":1764664029,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止11月30号，公司的股东人数是多少？谢谢上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年11月28日，公司股东总户数为110,144户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200021162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","002252","BK0196","BK0028","BK0046"],"gpt_icon":0},{"id":"2586277253","title":"上海莱士：公司未进口武田白蛋白","url":"https://stock-news.laohu8.com/highlight/detail?id=2586277253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586277253?lang=zh_cn&edition=full","pubTime":"2025-11-28 11:33","pubTimestamp":1764300832,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)11月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司是否有进口日本武田白蛋白？上海莱士回复：您好！感谢您对我公司的关心和支持！公司未进口武田白蛋白，公司代理的进口白蛋白为基立福相关产品。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800012295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002252","BK0188","BK0028","BK0046","BK0196"],"gpt_icon":0},{"id":"2584464983","title":"上海莱士(002252)11月10日股东户数11.24万户，较上期增加1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584464983","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584464983?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:37","pubTimestamp":1763372246,"startTime":"0","endTime":"0","summary":"证券之星消息，近日上海莱士披露，截至2025年11月10日公司股东户数为11.24万户，较10月20日增加1810.0户，增幅为1.64%。在生物制品行业个股中，上海莱士股东户数高于行业平均水平，截至11月10日，生物制品行业平均股东户数为3.45万户。从股价来看，2025年10月20日至2025年11月10日，上海莱士区间涨幅为3.6%，在此期间股东户数增加1810.0户，增幅为1.64%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202511/17/20251117657967.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202511/17/20251117657967.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251117/31802017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0196","BK0188","BK0028","BK0046","002252","BK0239"],"gpt_icon":0},{"id":"2581491716","title":"上海莱士(002252.SZ)：SR604注射液新增适应症获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2581491716","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581491716?lang=zh_cn&edition=full","pubTime":"2025-11-05 11:59","pubTimestamp":1762315187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海莱士 发布公告，公司于近日收到国家药品监督管理局核准签发的关于SR604注射液新增用于血管性血友病患者出血发作的预防治疗的《药物临床试验批准通知书》。截至本公告披露日，全球尚无与该药物同靶点的产品上市，也没有抗体药物获批上市用于血管性血友病的预防治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0196","002252","BK0188","BK0046","BK0239"],"gpt_icon":0},{"id":"2580807731","title":"上海莱士：回购股份用于员工持股计划或股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2580807731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580807731?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:48","pubTimestamp":1762260538,"startTime":"0","endTime":"0","summary":"前述已回购股份按照回购方案约定计划用于实施员工持股计划或股权激励，若未能按照《公司章程》的约定，在本次股份回购方案完成之日起一年内用于前述用途并转让给职工，未授予或转让的股份将依法予以注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400037006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0028","BK0196","002252","BK0239"],"gpt_icon":0},{"id":"2579450430","title":"上海莱士（002252）披露部分董事及全体高级管理人员增持股份计划实施完成公告，10月31日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579450430","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579450430?lang=zh_cn&edition=full","pubTime":"2025-10-31 18:35","pubTimestamp":1761906933,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，上海莱士报收于6.74元，较前一交易日上涨0.45%，最新总市值为447.4亿元。该股当日开盘6.71元，最高6.74元，最低6.7元，成交额达2.07亿元，换手率为0.46%。公司近日发布公告称，部分董事及全体高级管理人员增持股份计划已实施完成。本次增持后合计持股4,426,300股，占总股本0.067%。本次增持符合相关法律法规，未导致公司控制权变化或股权分布不符合上市条件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100040126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","002252","BK0196","BK0046"],"gpt_icon":0},{"id":"2579147127","title":"上海莱士：10月29日高管陆晖、黄勤兵增持股份合计2.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579147127","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579147127?lang=zh_cn&edition=full","pubTime":"2025-10-30 21:11","pubTimestamp":1761829907,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月30日市场公开信息、上市公司公告及交易所披露数据整理，上海莱士最新董监高及相关人员股份变动情况：2025年10月29日公司高管陆晖、高管黄勤兵共增持公司股份2.25万股，占公司总股本为0.0003%。上海莱士近半年内的董监高及核心技术人员增减持详情如下：上海莱士的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出2329.84万，融资余额减少；融券净流出5.39万，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000042514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002252","BK0028","BK0196","BK0188","BK0046"],"gpt_icon":0},{"id":"2579154374","title":"上海莱士：截至2025年10月20日股东总户数为110,595户","url":"https://stock-news.laohu8.com/highlight/detail?id=2579154374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579154374?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:54","pubTimestamp":1761785659,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)10月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月20号，公司的股东人数是多少？谢谢上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年10月20日，公司股东总户数为110,595户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000009650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0028","BK0239","BK0188","002252"],"gpt_icon":0},{"id":"2578630959","title":"上海莱士：本次回购方案已实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2578630959","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578630959?lang=zh_cn&edition=full","pubTime":"2025-10-28 22:08","pubTimestamp":1761660480,"startTime":"0","endTime":"0","summary":"证券日报网讯10月28日晚间，上海莱士发布公告称，截至2025年10月28日，本次回购方案已实施完毕。公司实际回购时间区间为2025年4月2日至2025年10月28日，公司通过股份回购专用证券账户以集中竞价交易方式累计回购股份69，081，952股，占公司总股本的1.04%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-28/doc-infvnhpf8707571.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-28/doc-infvnhpf8707571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0188","BK0028","BK0239","002252","BK0196"],"gpt_icon":0},{"id":"2578627860","title":"图解上海莱士三季报：第三季度单季净利润同比下降26.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578627860","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578627860?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:53","pubTimestamp":1761591236,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士2025年三季报显示，公司主营收入60.91亿元，同比下降3.54%；归母净利润14.71亿元，同比下降19.97%；扣非净利润14.85亿元，同比下降14.6%；其中2025年第三季度，公司单季度主营收入21.39亿元，同比上升3.72%；单季度归母净利润4.41亿元，同比下降26.16%；单季度扣非净利润4.45亿元，同比下降27.11%；负债率14.3%，投资收益2.69亿元，财务费用-4388.35万元，毛利率37.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252"],"gpt_icon":0},{"id":"2578470086","title":"上海莱士（002252）披露2025年前三季度利润分配预案，10月27日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578470086","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578470086?lang=zh_cn&edition=full","pubTime":"2025-10-27 22:18","pubTimestamp":1761574728,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，上海莱士报收于6.71元，较前一交易日下跌0.45%，最新总市值为445.41亿元。该股当日开盘6.73元，最高6.74元，最低6.7元，成交额达1.82亿元，换手率为0.41%。公司近日发布公告，拟实施2025年前三季度利润分配预案。2025年1-9月合并报表实现归属于母公司所有者净利润1,470,738,960.56元，年初未分配利润9,921,753,178.16元，已支付现金股利217,371,383.70元，截至2025年9月30日合并报表累计可供分配利润为11,175,120,755.02元。该预案尚需提交股东大会审议，符合相关法律法规及公司章程规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700036284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002252","BK0196","BK0046","BK0028","BK0188"],"gpt_icon":0},{"id":"2578659404","title":"股市必读：上海莱士（002252）10月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578659404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578659404?lang=zh_cn&edition=full","pubTime":"2025-10-27 02:02","pubTimestamp":1761501738,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，上海莱士报收于6.74元，上涨0.45%，换手率0.42%，成交量27.89万手，成交额1.88亿元。目前，广西莱士处于试生产阶段，待完成试生产及药品注册审批后，将逐步提升产量，达到稳定的运营状态。血液制品行业具有特殊属性，产量主要受采浆能力以及药品监管审批等诸多因素影响，公司将尽快推动广西莱士产品获批上市，实现稳定运营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700000560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","002252","BK0028","BK0196"],"gpt_icon":0},{"id":"2577930519","title":"上海莱士：公司已制定高级管理人员薪酬与绩效考核制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2577930519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577930519?lang=zh_cn&edition=full","pubTime":"2025-10-24 20:51","pubTimestamp":1761310295,"startTime":"0","endTime":"0","summary":"公司已制定《高级管理人员薪酬与绩效考核制度》，该制度经董事会审议通过并依法披露，后续将根据监管规则更新及公司实际经营情况持续完善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400040211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0188","002252","BK0028","BK0239"],"gpt_icon":0},{"id":"2576077093","title":"股市必读：上海莱士(002252)股东户数11.03万户，较上期增加0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576077093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576077093?lang=zh_cn&edition=full","pubTime":"2025-10-20 01:41","pubTimestamp":1760895668,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，上海莱士报收于6.66元，下跌0.75%，换手率0.5%，成交量32.98万手，成交额2.21亿元。交易信息汇总资金流向10月17日主力资金净流出3303.48万元；游资资金净流入2184.65万元；散户资金净流入1118.83万元。股本股东变化股东户数变动截至2025年10月10日，上海莱士股东户数为11.03万户，较9月30日增加602.0户，增幅0.55%；户均持股数量由6.05万股降至6.02万股，户均持股市值为40.92万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000000643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002252","BK0046","BK0196","BK0028"],"gpt_icon":0},{"id":"2576704971","title":"上海莱士：截至2025年10月10日股东总户数为110,316户","url":"https://stock-news.laohu8.com/highlight/detail?id=2576704971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576704971?lang=zh_cn&edition=full","pubTime":"2025-10-17 11:34","pubTimestamp":1760672043,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)10月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月10日的股东总户数是多少？上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年10月10日，公司股东总户数为110,316户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700015349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","002252","BK0188","BK0046","BK0239"],"gpt_icon":0},{"id":"2575334289","title":"股市必读：上海莱士(002252)股东户数10.97万户，较上期减少0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575334289","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575334289?lang=zh_cn&edition=full","pubTime":"2025-10-14 00:55","pubTimestamp":1760374517,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘，上海莱士报收于6.72元，下跌1.18%，换手率0.58%，成交量38.74万手，成交额2.6亿元。当日关注点来自交易信息汇总：10月13日主力资金净流出3315.9万元，显示主力短期谨慎态度。股本股东变化股东户数变动近日上海莱士披露，截至2025年9月30日公司股东户数为10.97万户，较9月19日减少145.0户，减幅为0.13%。户均持股数量由上期的6.04万股增加至6.05万股，户均持股市值为40.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400026877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252","BK0188","BK0046","BK0028","BK0239","BK0196"],"gpt_icon":0},{"id":"2574152671","title":"上海莱士回购6832万股 金额4.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574152671","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574152671?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:41","pubTimestamp":1760010060,"startTime":"0","endTime":"0","summary":"10月9日，上海莱士（002252）截至2025年9月30日累计回购6832万股，占总股本的1.03%，回购金额为4.7亿元，最高成交价为7.09元/股，最低成交价为6.62元/股。　　2025年中期，上海莱士实现收入39.52亿元，归母净利润10.30亿元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-09/doc-infticea9578822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0239","BK0046","BK0028","BK0196","002252"],"gpt_icon":0},{"id":"2571367651","title":"上海莱士：SR604预计明年上半年完成IIb期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2571367651","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571367651?lang=zh_cn&edition=full","pubTime":"2025-09-30 08:36","pubTimestamp":1759192579,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士09月29日在投资者关系平台上答复投资者关心的问题。投资者提问：关于sr604两个问题，1、目前IIb期预计什么时候完成可以进入下一阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000006573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252","BK0046","BK0028","BK0188","BK0239","BK0196"],"gpt_icon":0},{"id":"2571236751","title":"上海莱士：员工持股计划设营收与研发考核指标","url":"https://stock-news.laohu8.com/highlight/detail?id=2571236751","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571236751?lang=zh_cn&edition=full","pubTime":"2025-09-30 08:33","pubTimestamp":1759192386,"startTime":"0","endTime":"0","summary":"荣正咨询、中伦律所为公司本次员工持股计划分别出具了独立财务顾问报告以及法律意见书。本次员工持股计划在设定指标时，为体现激励与约束对等，兼顾激励效果和公司股东利益，充分调动和激发员工的主观能动性和工作积极性，该员工持股计划除设定了公司层面业绩考核指标外，还设定了个人层面绩效考核指标，以达到考核指标作为相应权益的解锁条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000006510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765746436328,"stockEarnings":[{"period":"1week","weight":-0.0287},{"period":"1month","weight":-0.0707},{"period":"3month","weight":-0.0571},{"period":"6month","weight":-0.0608},{"period":"1year","weight":-0.1618},{"period":"ytd","weight":-0.1038}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海莱士血液制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"110144人(较上一季度减少0.55%)","perCapita":"60234股","listingDate":"2008-06-23","address":"上海市奉贤区望园路2009号","registeredCapital":"663798万元","survey":"　　上海莱士血液制品股份有限公司的主营业务是血液制品的生产和销售。公司的主要产品是自产白蛋白、进口白蛋白、静丙、其他血液制品、检测设备及试剂。公司是“上海市外商投资先进技术企业”、“高新技术企业”。","listedPrice":12.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海莱士,002252,上海莱士股票,上海莱士股票老虎,上海莱士股票老虎国际,上海莱士行情,上海莱士股票行情,上海莱士股价,上海莱士股市,上海莱士股票价格,上海莱士股票交易,上海莱士股票购买,上海莱士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}